| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/22/2011 | CN101293905B Benzoxazole ketone glycoside compounds and preparation method thereof |
| 06/22/2011 | CN101259161B Production technology of cream for treating toothache and odontitis |
| 06/22/2011 | CN101239189B Tenofovir, adefovir and intelligent polymer conjugates and preparation and use thereof |
| 06/22/2011 | CN101209271B Medicinal composition for preventing helicobacter pylori |
| 06/22/2011 | CN101182563B Method for preparing lactulose by co-immobilized lactose enzyme and glucose isomerase |
| 06/22/2011 | CN101120789B Method for producing instant powder of cactus |
| 06/22/2011 | CN101085084B Oral liquid containing sophora flavescens, scutellaria and other medicine with diarrhea-stopping function |
| 06/22/2011 | CN100998776B Traditional Chinese medicine effervescent tablets for inducing sweat, cleaning damp and harmonizing middle-jiao, and its preparing method |
| 06/21/2011 | US7964732 Substituted bicyclocarboxyamide compounds |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964609 Use of mGluR5 antagonists for the treatment of gerd |
| 06/21/2011 | US7964581 Use of difructose anhydride-containing composition |
| 06/21/2011 | US7964374 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/21/2011 | US7964187 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 06/21/2011 | CA2486336C Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
| 06/21/2011 | CA2480223C A composition for treating gastric ulcer and a process for preparing the same |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
| 06/21/2011 | CA2462537C Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 06/21/2011 | CA2405547C Protective agent against reinfection after liver transplantation |
| 06/21/2011 | CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/21/2011 | CA2297408C Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
| 06/16/2011 | WO2011072216A2 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents |
| 06/16/2011 | WO2011072069A2 Gastric retentive pharmaceutical compositions for extended release of polypeptides |
| 06/16/2011 | WO2011071890A1 Methods for purifying monosaccharide mixtures containing ionic impurities |
| 06/16/2011 | WO2011071134A1 Prophylactic composition for influenza infection |
| 06/16/2011 | WO2011070970A1 Overexpression inhibitor of thymic stromal lymphopoietin |
| 06/16/2011 | WO2011070565A1 Glucans for treating or preventing food sensitivity |
| 06/16/2011 | WO2011069987A1 Infant formula with probiotics and milk fat globule membrane components |
| 06/16/2011 | WO2011069921A1 Sucrose octasulfates of zinc, the preparation of same and the pharmaceutical and cosmetic uses thereof |
| 06/16/2011 | WO2011069408A1 Polypeptide immunogen, preparation method and use thereof |
| 06/16/2011 | WO2011022838A8 Polyhydroxylated bile acids for treatment of biliary disorders |
| 06/16/2011 | WO2011020095A3 Compositions and methods of treating inflammation |
| 06/16/2011 | WO2011019210A3 Dietary supplement, feed and pharmaceutical composition containing chia seed and maca, and preparation method thereof |
| 06/16/2011 | US20110144330 2,4-Pyrimidinediamine Compounds and their Uses |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144174 Deuterium-enriched odansetron |
| 06/16/2011 | US20110144170 Fc RECEPTOR MODULATING COMPOUNDS AND COMPOSITIONS |
| 06/16/2011 | US20110144161 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 06/16/2011 | US20110144159 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors |
| 06/16/2011 | US20110144157 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 06/16/2011 | US20110144152 Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 06/16/2011 | US20110144134 Anti-Inflammatory Pyrazolopyrimndines |
| 06/16/2011 | US20110144115 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/16/2011 | US20110144110 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/16/2011 | US20110144108 Substituted piperidine compounds and methods of their use |
| 06/16/2011 | US20110144102 Calcimimetic compound for use in the treatment of epithelial injury |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144059 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 06/16/2011 | US20110144051 Compositions and methods for treatment of mitochondrial diseases |
| 06/16/2011 | US20110144041 Methods for Treating Inflammatory Bowel Disease |
| 06/16/2011 | US20110144039 Antioxidative and hepatoprotective compositions containing diaryheptanoids from alnus japonica |
| 06/16/2011 | US20110144036 HIP/PAP Polypeptide Composition for Use in Liver Regeneration and for the Prevention of Liver Failure |
| 06/16/2011 | US20110144021 Therapeutic proteins from latex |
| 06/16/2011 | US20110144020 Treatment of infections and other disorders |
| 06/16/2011 | US20110143995 Novel anti-allergic agents |
| 06/16/2011 | US20110143992 Methods and Compositions Related to GHS-R Antagonists |
| 06/16/2011 | US20110142966 Aqueous extracts of anoectochilus spp. kinsenoside and pharmaceutical compositions useful for hepatoprotection |
| 06/16/2011 | US20110142962 Oral Rehydration Solutions Comprising Dextrose |
| 06/16/2011 | US20110142929 Solid pharmaceutical formulations comprising bibw 2992 |
| 06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
| 06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
| 06/16/2011 | US20110142905 Coated tablets with remaining degradation surface over the time |
| 06/16/2011 | US20110142886 Pegylated polyplexes for polynucleotide delivery |
| 06/16/2011 | US20110142879 Infectious clones |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | US20110142833 Methods for treating and preventing fibrosis |
| 06/16/2011 | US20110142831 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 06/16/2011 | US20110142817 Means and method for treating and/or preventing necrotizing enterocolitis |
| 06/16/2011 | US20110142807 Mesenchymal Stem Cells and Uses Therefor |
| 06/16/2011 | US20110142801 Protease resistant modified interferon-beta polypeptides and their use in treating diseases |
| 06/16/2011 | US20110142765 Novel phloroglucinol derivatives having selectin ligand activity |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | US20110139654 Oxadiazole derivatives for the treatment of diabetes |
| 06/16/2011 | US20110138888 Treatment of obesity |
| 06/16/2011 | CA2783768A1 Infant formula with probiotics and milk fat globule membrane components |
| 06/16/2011 | CA2783701A1 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents |
| 06/16/2011 | CA2783342A1 Gastric retentive pharmaceutical compositions for extended release of polypeptides |
| 06/16/2011 | CA2783198A1 Methods for purifying monosaccharide mixtures containing ionic impurities |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332568A1 Collagenase for opening obstructed biological conduits |
| 06/15/2011 | EP2332556A1 Use of yeasts for treating stomach or intestinal ulcers induced by gastrotoxic agents |
| 06/15/2011 | EP2332550A1 Tetracyclines for the treatment of neurodegenerative diseases |
| 06/15/2011 | EP2332549A1 Novel tetracyclines and their use in medicine |
| 06/15/2011 | EP2332548A1 Tetracyclines for the treatment of stroke |
| 06/15/2011 | EP2332547A1 Tetracyclines for the treatment of inflammatory bowel disease |
| 06/15/2011 | EP2332546A1 Tetracyclines for the treatment of stroke |
| 06/15/2011 | EP2332541A1 Use of thioxanthine derivatives as MPO inhibitors |
| 06/15/2011 | EP2332535A1 Solid pharmaceutical composition |
| 06/15/2011 | EP2332523A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 06/15/2011 | EP2332414A2 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 06/15/2011 | EP2331122A2 A vaccine for porcine post-weaning diarrhea caused by enterotoxigenic escherichia coli |
| 06/15/2011 | EP2081939B1 Benzimidazole derivatives as selective acid pump inhibitors |